Kourosh Rezania Selected Research

Kourosh Rezania Research Topics

Disease

6	Myasthenia Gravis 04/2021 - 02/2009
5	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021 - 09/2003
3	Thymoma (Thymic Carcinoma) 05/2021 - 01/2013
3	Autoimmune Diseases (Autoimmune Disease) 04/2021 - 03/2012
2	Amyloidosis 03/2022 - 06/2013
2	Neoplasms (Cancer) 01/2021 - 06/2019
1	Mononeuropathies (Mononeuritis Multiplex) 03/2022
1	Transthyretin-Related Hereditary Amyloidosis 03/2022
1	Renal Insufficiency (Renal Failure) 04/2021
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021
1	Nausea 01/2021
1	Thymus Neoplasms (Thymus Neoplasm) 01/2021
1	Fatigue 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 10/2019
1	Respiratory Insufficiency (Respiratory Failure) 10/2019
1	Guillain-Barre Syndrome 06/2019
1	Multiple Sclerosis 06/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019
1	Diabetic Neuropathies (Diabetic Neuropathy) 10/2016
1	Pneumothorax 08/2016
1	Experimental Autoimmune Myasthenia Gravis (Autoimmune Experimental Myasthenia Gravis) 01/2016
1	Venous Thrombosis (Deep-Vein Thrombosis) 11/2014
1	Susac Syndrome 01/2014
1	Central Nervous System Diseases (CNS Diseases) 01/2014
1	Pain (Aches) 03/2013
1	Migraine Disorders (Migraine) 03/2013
1	Migraine without Aura (Common Migraine) 03/2013
1	Neuralgia (Stump Neuralgia) 01/2013
1	Isaacs Syndrome (Neuromyotonia) 01/2013
1	Insulin Resistance 04/2011
1	Chronic Pain 04/2011
1	Inflammation (Inflammations) 04/2011
1	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2009
1	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 01/2004

Drug/Important Bio-Agent (IBA)

3	AntibodiesIBA 04/2021 - 03/2012
2	Valine (L-Valine)FDA Link 03/2022 - 09/2003
2	Prealbumin (Transthyretin)IBA 03/2022 - 06/2013
2	AutoantibodiesIBA 05/2021 - 04/2021
2	Cholinergic ReceptorsIBA 04/2021 - 03/2012
2	Immune Checkpoint InhibitorsIBA 04/2021 - 01/2021
2	pembrolizumabIBA 01/2021 - 01/2019
2	NivolumabIBA 06/2019 - 01/2019
2	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 10/2014 - 01/2013
1	Isoleucine (L-Isoleucine)FDA Link 03/2022
1	Anesthetics (Anesthetic Agents)IBA 04/2021
1	Neuromuscular Blocking AgentsIBA 04/2021
1	Tyrosine Kinase InhibitorsIBA 04/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2021
1	Proteins (Proteins, Gene)FDA Link 04/2021
1	InterferonsIBA 04/2021
1	Penicillamine (Cuprimine)FDA Link 04/2021
1	reldesemtivIBA 01/2021
1	Bile Acids and Salts (Bile Acids)IBA 12/2020
1	LigandsIBA 10/2019
1	avelumabIBA 10/2019
1	Programmed Cell Death 1 ReceptorIBA 10/2019
1	VaccinesIBA 06/2019
1	IpilimumabIBA 01/2019
1	atezolizumabIBA 01/2019
1	Insulin (Novolin)FDA Link 10/2016
1	Interleukin-10 (Interleukin 10)IBA 01/2016
1	Cephalosporins (Cephalosporin Antibiotics)IBA 10/2014
1	Retinaldehyde (Retinal)IBA 01/2014
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2014
1	Tryptamines (Triptans)IBA 03/2013
1	Valproic Acid (Depakote)FDA LinkGeneric 03/2013
1	Sumatriptan (Imigran)FDA LinkGeneric 03/2013
1	Metoclopramide (Reglan)FDA LinkGeneric 03/2013
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 01/2013
1	muskIBA 03/2012
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2012
1	CatecholaminesIBA 04/2011
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2011
1	AntioxidantsIBA 08/2009
1	coenzyme Q10 (CoQ10)IBA 08/2009
1	Terbutaline (Brethaire)FDA LinkGeneric 02/2009
1	Immunologic Factors (Immunomodulators)IBA 01/2004
1	Codon (Codons)IBA 09/2003
1	Alanine (L-Alanine)FDA Link 09/2003
1	Superoxide Dismutase-1IBA 09/2003

Therapy/Procedure

2	Aftercare (After-Treatment) 01/2021 - 06/2019
1	Liver Transplantation 03/2022
1	Therapeutics 06/2019
1	Immunotherapy 06/2019
1	Gastrostomy 01/2017
1	Transplantation 10/2016
1	Glycemic Control 10/2016
1	Central Venous Catheters 08/2016
1	Thymectomy 08/2016
1	Plasmapheresis 08/2016
1	Operative Surgical Procedures 11/2014
1	Drug Therapy (Chemotherapy) 01/2013